Granules Pharmaceuticals Inc. recalled 3,384 bottles of amphetamine capsules on August 28, 2025. The recall follows a failure to meet impurities and degradation specifications. Consumers should stop using this product immediately and consult healthcare providers.
Failed Impurities/Degradation Specifications:
Consumers and healthcare providers should stop using this product immediately. Contact Granules Pharmaceuticals Inc. or your healthcare provider for guidance. Notification method: E-Mail
The recall involves Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, 100 capsules per bottle. The affected lot number is GPC250158A, with an expiration date of June 22, 2027.
The product failed to meet established impurities and degradation specifications. This could pose health risks to users, particularly affecting efficacy and safety.
No specific incidents or injuries were reported in connection with this recall. However, the nature of the degradation could potentially impact patients using the medication.
Consumers and healthcare providers should stop using the affected capsules immediately. Contact Granules Pharmaceuticals Inc. or your healthcare provider for guidance on next steps.
For more information, consumers can email Granules Pharmaceuticals Inc. or visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0669-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.